Literature DB >> 21406687

A complex double deletion in LMNA underlies progressive cardiac conduction disease, atrial arrhythmias, and sudden death.

Roos F Marsman1, Abdennasser Bardai, Alex V Postma, Jan C J Res, Tamara T Koopmann, Leander Beekman, Allard C van der Wal, Yigal M Pinto, Ronald H Lekanne Deprez, Arthur A M Wilde, Luc J Jordaens, Connie R Bezzina.   

Abstract

BACKGROUND: Cardiac conduction disease is a clinically and genetically heterogeneous disorder characterized by defects in electrical impulse generation and conduction and is associated with sudden cardiac death. METHODS AND
RESULTS: We studied a 4-generation family with autosomal dominant progressive cardiac conduction disease, including atrioventricular conduction block and sinus bradycardia, atrial arrhythmias, and sudden death. Genome-wide linkage analysis mapped the disease locus to chromosome 1p22-q21. Multiplex ligation-dependent probe amplification analysis of the LMNA gene, which encodes the nuclear-envelope protein lamin A/C, revealed a novel gene rearrangement involving a 24-bp inversion flanked by a 3.8-kb deletion upstream and a 7.8-kb deletion downstream. The presence of short inverted sequence homologies at the breakpoint junctions suggested a mutational event involving serial replication slippage in trans during DNA replication.
CONCLUSIONS: We identified for the first time a complex LMNA gene rearrangement involving a double deletion in a 4-generation Dutch family with progressive conduction system disease. Our findings underscore the fact that if conventional polymerase chain reaction-based direct sequencing approaches for LMNA analysis are negative in suggestive pedigrees, mutation detection techniques capable of detecting gross genomic lesions involving deletions and insertions should be considered.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21406687     DOI: 10.1161/CIRCGENETICS.110.959221

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN: 1942-3268


  7 in total

Review 1.  Genetic variations involved in sudden cardiac death and their associations and interactions.

Authors:  Dazhen Wei; Luyuan Tao; Mingyuan Huang
Journal:  Heart Fail Rev       Date:  2016-07       Impact factor: 4.214

2.  Genetic basis and molecular biology of cardiac arrhythmias in cardiomyopathies.

Authors:  Ali J Marian; Babken Asatryan; Xander H T Wehrens
Journal:  Cardiovasc Res       Date:  2020-07-15       Impact factor: 10.787

3.  Lamin A mutation impairs interaction with nucleoporin NUP155 and disrupts nucleocytoplasmic transport in atrial fibrillation.

Authors:  Meng Han; Miao Zhao; Chen Cheng; Yuan Huang; Shengna Han; Wenjuan Li; Xin Tu; Xuan Luo; Xiaoling Yu; Yinan Liu; Qiuyun Chen; Xiang Ren; Qing Kenneth Wang; Tie Ke
Journal:  Hum Mutat       Date:  2018-12-08       Impact factor: 4.878

4.  What Should the Cardiologist know about Lamin Disease?

Authors:  Philippe Charron; Eloisa Arbustini; Gisèle Bonne
Journal:  Arrhythm Electrophysiol Rev       Date:  2012-09

5.  Identification of fibrillin 1 gene mutations in patients with bicuspid aortic valve (BAV) without Marfan syndrome.

Authors:  Guglielmina Pepe; Stefano Nistri; Betti Giusti; Elena Sticchi; Monica Attanasio; Cristina Porciani; Rosanna Abbate; Robert O Bonow; Magdi Yacoub; Gian Franco Gensini
Journal:  BMC Med Genet       Date:  2014-02-24       Impact factor: 2.103

6.  Your Father and Grandfather's Atrial Fibrillation: A Review of the Genetics of the Most Common Pathologic Cardiac Dysrhythmia.

Authors:  Joseph A Palatinus; Saumya Das
Journal:  Curr Genomics       Date:  2015-04       Impact factor: 2.236

7.  Whole-exome sequencing to identify a novel LMNA gene mutation associated with inherited cardiac conduction disease.

Authors:  Chun-Chi Lai; Yung-Hsin Yeh; Wen-Ping Hsieh; Chi-Tai Kuo; Wen-Ching Wang; Chia-Han Chu; Chiu-Lien Hung; Chia-Yang Cheng; Hsin-Yi Tsai; Jia-Lin Lee; Chuan-Yi Tang; Lung-An Hsu
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.